Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma.
about
Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studiesLong-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature.Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review.Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib.Dietary supplementation in cancer patients: a personal view of current status and future perspectives.Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
P2860
Complete regression following sorafenib in unresectable, locally advanced hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Complete regression following ...... nced hepatocellular carcinoma.
@en
Complete regression following ...... nced hepatocellular carcinoma.
@nl
type
label
Complete regression following ...... nced hepatocellular carcinoma.
@en
Complete regression following ...... nced hepatocellular carcinoma.
@nl
prefLabel
Complete regression following ...... nced hepatocellular carcinoma.
@en
Complete regression following ...... nced hepatocellular carcinoma.
@nl
P2860
P356
P1433
P1476
Complete regression following ...... nced hepatocellular carcinoma.
@en
P2093
Laura Zanlorenzi
Marco Moroni
P2860
P304
P356
10.2217/FON.13.86
P407
P577
2013-08-01T00:00:00Z